Disc Col

Save items

loading

Similar articles

Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8<sup>+</sup> invariant natural killer T cells.[Clin Immunol. 2017]
Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8<sup>+</sup> invariant natural killer T cells.
Ghnewa YG, O'Reilly VP, Vandenberghe E, Browne PV, McElligott AM, Doherty DG. Clin Immunol. 2017 Oct; 183:91-98. Epub 2017 Aug 3.
Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines.[Methods Mol Biol. 2014]
Exploiting the CD1d-iNKT cell axis for potentiation of DC-based cancer vaccines.
Lameris R, Schneiders FL, de Gruijl TD, van der Vliet HJ. Methods Mol Biol. 2014; 1139:155-65.
All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses.[Immunobiology. 2015]
All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses.
Chen Q, Ross AC. Immunobiology. 2015 Jan; 220(1):32-41. Epub 2014 Sep 16.
Review Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.[Tissue Antigens. 2009]
Review Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L, Gabriel CL, Parekh VV, Van Kaer L. Tissue Antigens. 2009 Jun; 73(6):535-45. Epub 2009 Apr 8.
Review Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.[Immunology. 2012]
Review Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V. Immunology. 2012 Sep; 137(1):20-7.

See reviews...See all...

Cited by 10 PubMed Central articles

Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia.[Oncol Lett. 2018]
Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia.
Bojarska-Junak A, Waldowska M, Woś J, Chocholska S, Hus I, Tomczak W, Dzik M, Hus M, Roliński J. Oncol Lett. 2018 Feb; 15(2):1580-1590. Epub 2017 Nov 24.
Review Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.[Front Immunol. 2017]
Review Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.
Lam PY, Nissen MD, Mattarollo SR. Front Immunol. 2017; 8:1355. Epub 2017 Oct 23.
Review A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies.[Cent Eur J Immunol. 2017]
Review A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies.
Waldowska M, Bojarska-Junak A, Roliński J. Cent Eur J Immunol. 2017; 42(2):181-195. Epub 2017 Aug 8.

See all...

Related information

MedGen
Related information in MedGen
PubChem Compound (MeSH Keyword)
Related PubChem Compound via MeSH
References for this PMC Article
References for this PMC Article
Free in PMC
Free full text articles in PMC
Cited in PMC
PubMed links associated with PMC

Recent Activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on